Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20052460HPVENSG00000140538.17protein_codingNTRK3YesNo4916B7Z7U4
O95193
Q16288
Q96CY4
X5D2R1
X5D7M5
X5DNW6
TVIS20052219HPVENSG00000140538.17protein_codingNTRK3YesNo4916B7Z7U4
O95193
Q16288
Q96CY4
X5D2R1
X5D7M5
X5DNW6
TVIS20025710HPVENSG00000140538.17protein_codingNTRK3YesNo4916B7Z7U4
O95193
Q16288
Q96CY4
X5D2R1
X5D7M5
X5DNW6
TVIS20052214HPVENSG00000140538.17protein_codingNTRK3YesNo4916B7Z7U4
O95193
Q16288
Q96CY4
X5D2R1
X5D7M5
X5DNW6
TVIS20052332HPVENSG00000140538.17protein_codingNTRK3YesNo4916B7Z7U4
O95193
Q16288
Q96CY4
X5D2R1
X5D7M5
X5DNW6
TVIS20052468HPVENSG00000140538.17protein_codingNTRK3YesNo4916B7Z7U4
O95193
Q16288
Q96CY4
X5D2R1
X5D7M5
X5DNW6
TVIS44023739HTLV-1ENSG00000140538.17protein_codingNTRK3YesNo4916B7Z7U4
O95193
Q16288
Q96CY4
X5D2R1
X5D7M5
X5DNW6
TVIS44009278HTLV-1ENSG00000140538.17protein_codingNTRK3YesNo4916B7Z7U4
O95193
Q16288
Q96CY4
X5D2R1
X5D7M5
X5DNW6
TVIS44006499HTLV-1ENSG00000140538.17protein_codingNTRK3YesNo4916B7Z7U4
O95193
Q16288
Q96CY4
X5D2R1
X5D7M5
X5DNW6
TVIS44027250HTLV-1ENSG00000140538.17protein_codingNTRK3YesNo4916B7Z7U4
O95193
Q16288
Q96CY4
X5D2R1
X5D7M5
X5DNW6
TCGA Plot Options
Drug Information
GeneNTRK3
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0009501
UniProt IDQ16288
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830